Medindia
Medindia LOGIN REGISTER
Advertisement

Amedica Receives CE Mark for the World's First FDA-Cleared Valeo(TM) Ceramic Spinal Implant System

Wednesday, November 12, 2008 General News
Advertisement
SALT LAKE CITY, Nov. 12 Amedica Corporation, an orthopedicimplants company focused on silicon nitride ceramic technologies, announcedtoday that it has received a CE (Conformite Europeene) mark for its Valeo(TM)family of ceramic spinal intervertebral spacers. This family includesValeo - C and Valeo - TL spacers made using Amedica's novel silicon nitrideceramic for surgical correction or stabilization of the spine. This familyreceived FDA clearance in January 2008, for sale in the United States asvertebral body replacements.
Advertisement

The Valeo family of ceramic spinal intervertebral spacers is intended toaid in surgical correction and stabilization of the thoracolumbar spine.These implants are designed to restore the biomechanical integrity of theanterior, middle and posterior spine, even in the absence of fusion, for aprolonged period of time. The Valeo family of spacers provides newfunctionalities compared to competing devices currently on the market and isbelieved to be the first family of silicon nitride ceramic implants availablefor spinal use in the world.
Advertisement

"Amedica's ceramic spinal spacers uniquely combine strength with animproved bone/implant interface and bone like imaging compatibility, makingthem a valuable alternative to currently available devices using conventionalsynthetic materials," said Darrel Brodke, M.D., Professor and Vice-Chair,Director of Spine Service, Department of Orthopaedics, University of UtahSchool of Medicine. "Because these implants have a combination ofdistinguishing features, I would expect Amedica's implants to be well receivedin Europe and Asia, where allograft bone is not frequently used."

"Obtaining the CE mark for our Valeo ceramic spinal spacers expands ourability to bring our portfolio of innovative spinal implant products toimportant markets in Europe, Asia and other regions of the world," said AshokKhandkar, Ph.D., Chief Executive Officer of Amedica Corporation. "Thisachievement gives us the ability to begin to educate and train physicians inEurope and other foreign markets so that more patients can benefit from ourinnovative implants."

About Amedica

Amedica Corporation is an emerging orthopedic implant company focused onusing its silicon nitride ceramic technologies to develop and commercialize abroad range of innovative, high-performance spine and joint implants for thegrowing orthopedic device market. Its products under development includespine, reconstructive hip and knee implants that may represent a new standardof care in total joint implants based on superior durability, performance andsafety.

SOURCE Amedica Corporation
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close